These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21692140)

  • 1. A descriptive study evaluating Health Canada's risk communications.
    Bateman J; Charrois TL; Gardiner P; Vohra S
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1104-9. PubMed ID: 21692140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarket surveillance of natural health products in Canada: clinical and federal regulatory perspectives.
    Murty M
    Can J Physiol Pharmacol; 2007 Sep; 85(9):952-5. PubMed ID: 18066142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians.
    Levine MA; Xu S; Gaebel K; Brazier N; Bédard M; Brazil K; Lohfeld L; MacLeod SM
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):383-92. PubMed ID: 20129259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural health product use in Canada: analysis of the National Population Health Survey.
    Singh SR; Levine MA
    Can J Clin Pharmacol; 2006; 13(2):e240-50. PubMed ID: 16921199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of natural health products in Canada.
    Smith A; Jogalekar S; Gibson A
    J Ethnopharmacol; 2014 Dec; 158 Pt B():507-10. PubMed ID: 24969823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community identification of natural health product-drug interactions.
    Charrois TL; Hill RL; Vu D; Foster BC; Boon HS; Cramer K; Vohra S
    Ann Pharmacother; 2007 Jul; 41(7):1124-9. PubMed ID: 17578882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of NHP-drug interactions: identification and evaluation.
    Brulotte J; Vohra S
    Curr Drug Metab; 2008 Dec; 9(10):1049-54. PubMed ID: 19075621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of natural health product use in healthy postmenopausal women.
    Daoust JL; Mercer LC; Duncan AM
    Menopause; 2006; 13(2):241-50. PubMed ID: 16645538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of natural health products by paediatric patients in respite care.
    Beringer A; Vaillancourt R; Villarreal G; Vadeboncoeur C
    Paediatr Child Health; 2015; 20(1):23-9. PubMed ID: 25722640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model competencies in regulatory therapeutic product assessment: Health Canada's good review guiding principles as a reviewing community's code of intellectual conduct.
    Lim RR
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):933-41. PubMed ID: 17290483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    BMC Health Serv Res; 2006 May; 6():63. PubMed ID: 16734916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of natural health products on blood pressure.
    Richard CL; Jurgens TM
    Ann Pharmacother; 2005 Apr; 39(4):712-20. PubMed ID: 15741425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Canada's use of its priority review process for new drugs: a cohort study.
    Lexchin J
    BMJ Open; 2015 May; 5(5):e006816. PubMed ID: 25967989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Governance of natural health products regulation: an iterative process.
    Walji R; Wiktorowicz M
    Health Policy; 2013 Jun; 111(1):86-94. PubMed ID: 23523344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
    Cassels A; Hughes MA; Cole C; Mintzes B; Lexchin J; McCormack JP
    CMAJ; 2003 Apr; 168(9):1133-7. PubMed ID: 12719316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dietitians in providing guidance on the use of natural health products.
    Mihalynuk T; Whiting S
    Can J Diet Pract Res; 2013; 74(2):58-62. PubMed ID: 23750976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013).
    Almuzaini T; Sammons H; Choonara I
    BMJ Open; 2014 Oct; 4(10):e006088. PubMed ID: 25361839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions with herbal products: what do we know?
    Drug Ther Bull; 2014 Feb; 52(2):18-21. PubMed ID: 24525006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential interactions of drug-natural health products and natural health products-natural health products among children.
    Goldman RD; Rogovik AL; Lai D; Vohra S
    J Pediatr; 2008 Apr; 152(4):521-6, 526.e1-4. PubMed ID: 18346508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.